Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. The company is also discovering drug targets for the treatments of duchenne muscular dystrophy, friedreich ataxia, myotonic dystrophy 1, and a-synucleinopathies, as well as neurological and pulmonary diseases. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
---|---|---|---|---|---|---|---|
2021-03-16 | Gould Robert J | Director | Sell | 10,000 | $12.16 | $121,578 | No |
2021-02-22 | Thomson Peter G. | VP Finance & Accounting | Sell | 5,000 | $14.72 | $73,582 | Yes |
2021-02-16 | Gould Robert J | Director | Sell | 8,215 | $14.27 | $117,197 | No |
2021-01-21 | Thomson Peter G. | VP Finance & Accounting | Sell | 6,607 | $14.00 | $92,498 | No |
2021-01-20 | Gould Robert J | Director | Sell | 10,000 | $12.08 | $120,826 | No |
2020-07-08 | Wallace Owen B. | Chief Scientific Officer | Sell | 2,951 | $20.00 | $59,020 | Yes |
2020-07-08 | Gould Robert J | Director | Sell | 2,500 | $20.00 | $50,000 | No |
2020-07-01 | Cadavid Diego | SVP Clinical Development | Sell | 1,071 | $18.30 | $19,599 | No |
2020-06-30 | Wallace Owen B. | Chief Scientific Officer | Sell | 141 | $20.00 | $2,820 | Yes |
2020-06-25 | Cadavid Diego | SVP Clinical Development | Sell | 1,459 | $22.00 | $32,098 | Yes |
2020-06-25 | Gould Robert J | Director | Sell | 2,500 | $20.80 | $51,992 | No |
2020-06-10 | Cadavid Diego | SVP Clinical Development | Sell | 401 | $22.00 | $8,822 | Yes |
2020-06-09 | Gould Robert J | Director | Sell | 156 | $20.00 | $3,120 | No |
2020-06-05 | Gould Robert J | Director | Sell | 3,433 | $20.17 | $69,251 | No |
2020-06-05 | Cadavid Diego | SVP Clinical Development | Sell | 677 | $20.14 | $13,632 | Yes |
2020-06-04 | Gould Robert J | Director | Sell | 2,800 | $20.09 | $56,250 | No |
2020-06-03 | Cadavid Diego | SVP Clinical Development | Sell | 383 | $20.16 | $7,720 | Yes |
2020-06-02 | Gould Robert J | Director | Sell | 2,802 | $20.00 | $56,040 | No |
2020-05-29 | Cadavid Diego | SVP Clinical Development | Sell | 800 | $20.01 | $16,007 | Yes |
2020-05-29 | Gould Robert J | Director | Sell | 3,309 | $20.04 | $66,302 | No |
2020-05-28 | Wallace Owen B. | Chief Scientific Officer | Sell | 2,232 | $20.00 | $44,640 | Yes |
2020-05-27 | Wallace Owen B. | Chief Scientific Officer | Sell | 448 | $20.00 | $8,960 | Yes |
2020-05-26 | Wallace Owen B. | Chief Scientific Officer | Sell | 412 | $20.00 | $8,240 | Yes |
2020-05-26 | Gould Robert J | Director | Sell | 2,500 | $20.00 | $50,000 | No |
2020-05-12 | Cadavid Diego | SVP Clinical Development | Sell | 1,860 | $18.00 | $33,480 | Yes |
2020-05-11 | Thomson Peter G. | VP Finance & Accounting | Sell | 7,500 | $16.00 | $120,000 | No |
2020-03-02 | Cadavid Diego | SVP Clinical Development | Sell | 2,143 | $17.38 | $37,255 | No |
2020-02-24 | Thomson Peter G. | VP Finance & Accounting | Sell | 5,000 | $16.83 | $84,153 | No |
2020-02-19 | Gould Robert J | See Remarks | Sell | 2,500 | $20.00 | $50,000 | No |
2020-02-19 | Wallace Owen B. | Chief Scientific Officer | Sell | 6,088 | $20.00 | $121,760 | Yes |
Insider Smart
Insider Smart